Advertisement
Singapore markets open in 6 hours 58 minutes
  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     
  • S&P 500

    5,009.99
    -12.22 (-0.24%)
     
  • Dow

    37,724.58
    -28.73 (-0.08%)
     
  • Nasdaq

    15,618.06
    -65.32 (-0.42%)
     
  • Bitcoin USD

    62,833.86
    +1,578.16 (+2.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Gold

    2,398.10
    +9.70 (+0.41%)
     
  • Crude Oil

    82.88
    +0.19 (+0.23%)
     
  • 10-Yr Bond

    4.6390
    +0.0540 (+1.18%)
     
  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     
  • Jakarta Composite Index

    7,166.81
    +35.97 (+0.50%)
     
  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Is Vertex Pharmaceuticals Stock a Buy Now?

Is Vertex Pharmaceuticals Stock a Buy Now?

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) spiked recently in response to good news for an experimental new drug. Successful results from a clinical trial with a drug that isn't part of the company's successful cystic fibrosis franchise are generating a lot of stock market buzz for Vertex Pharmaceuticals again. On Dec. 1, 2021, Vertex Pharmaceuticals' stock jumped after the company posted results from a human proof-of-concept study with VX-147.